Phase I study of docetaxel in combination with Gemcitabine as first line chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Gatzemeier, U
Bildat, S
Harstrick, A
Eberhardt, W
Achterrath, W
Krauss, C
Wilke, HJ
机构：
[1] Rhone Poulenc Rorer, Cologne, Germany
[2] W German Canc Ctr, Essen, Germany
[3] Krankenhaus, Grosshansdorf, Germany
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
448
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [21] Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer
    Passardi, Alessandro
    Cecconetto, Lorenzo
    Dall'Agata, Monia
    Dazzi, Claudio
    Pasquini, Enzo
    Oliverio, Giovanni
    Zumaglini, Federica
    Zoli, Wainer
    Nanni, Oriana
    Milandri, Carlo
    Frassineti, Giovanni Luca
    Amadori, Dino
    JOURNAL OF TRANSLATIONAL MEDICINE, 2008, 6 (1)
  • [22] Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer
    Alessandro Passardi
    Lorenzo Cecconetto
    Monia Dall'Agata
    Claudio Dazzi
    Enzo Pasquini
    Giovanni Oliverio
    Federica Zumaglini
    Wainer Zoli
    Oriana Nanni
    Carlo Milandri
    Giovanni Luca Frassineti
    Dino Amadori
    Journal of Translational Medicine, 6
  • [23] A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer
    Seto, T
    Yoh, K
    Asoh, H
    Yamamoto, H
    Semba, H
    Ichinose, Y
    BRITISH JOURNAL OF CANCER, 2002, 86 (11) : 1701 - 1704
  • [24] A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer
    T Seto
    K Yoh
    H Asoh
    H Yamamoto
    H Semba
    Y Ichinose
    British Journal of Cancer, 2002, 86 : 1701 - 1704
  • [25] First line durvalumab and tremelimumab in combination with chemotherapy for non- oncogene addicted metastatic non-small cell lung cancer (NSCLC)
    Porte, Marie
    Pierret, Thomas
    BULLETIN DU CANCER, 2023, 110 (11) : 1094 - 1096
  • [26] Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer
    Chiappori, A
    Simon, G
    Williams, C
    Haura, E
    Rocha-Lima, C
    Wagner, H
    Bepler, G
    Antonia, S
    ONCOLOGY, 2005, 68 (4-6) : 382 - 390
  • [27] Combination of Gemcitabine (Gem) and Carboplatin (Carbo) as first line treatment in non-small cell lung cancer (NSCLC)
    Carrato, A
    Alberola, V
    Massuti, B
    Galan, A
    Sanchez, JJ
    Garcia-Gomez, J
    Diaz-Fernandez, N
    Meana, A
    Rodriguez-Lescure, A
    Gonzalvez, ML
    ANNALS OF ONCOLOGY, 1998, 9 : 89 - 90
  • [28] Phase II trial of weekly docetaxel and carboplatin as first line chemotherapy in advanced or metastatic non small cell lung cancer (NSCLC).
    Chahine, GY
    Nasr, FL
    Kattan, JG
    Farhat, FS
    El Seoudi, ME
    Bachour, M
    Moukadem, WT
    Younes, FC
    Ghosn, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 702S - 702S
  • [29] Phase II study of docetaxel and oxaliplatin in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer (NSCLC).
    Raez, L. E.
    Brito, R.
    Kobina, S.
    Perdekamp, M. G.
    Karr, M.
    Santos, E. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results.
    Mueller, A
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Pilz, L
    Mezger, J
    Manegold, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 640S - 640S
12345